Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Controlling Hypertension Cuts Stroke Risk

Works even for patients with normal blood pressure

By Ed Edelson
HealthScoutNews Reporter


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Shutting Down Tremor.
Disaster Heart Attacks
Teaching Old Docs New Tricks
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Animation: What is Hypertension?
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Drugs Provide Same Benefit as Angioplasty for Diabetics, at Lower Cost
Study: Migraine Raises Risk of Stroke
Low Vitamin D Tied to Estrogen Decline
All Ages at Risk for H1N1 Complications
More...

THURSDAY, Sept. 27 (HealthScoutNews) -- Drug treatment to lower blood pressure can reduce the risk of strokes for high-risk patients even if their blood pressure is not abnormally elevated, an international study finds.

Combination drug therapy with two standard blood pressure medications, an ACE inhibitor and a diuretic, reduced the incidence of stroke by almost 30 percent for patients who already had suffered strokes or transient ischemic attacks (TIAs),which are temporary interruptions of blood flow to the brain that often precede a stroke, says a report in the Sept. 29 issue of The Lancet.

The study included more than 6,000 patients at 172 medical centers in Asia, Australasia and Europe. All had experienced strokes or TIAs. Some had hypertension -- high blood pressure -- which the study defined as a reading of 160 over 95; some had blood pressure lower than those levels. Half of them were given a placebo, an inactive substance. The other half were given an ACE inhibitor, sometimes accompanied by a diuretic.

Text Continues Below



In a four-year follow-up, the incidence of stroke in patients getting the two-drug regimen was 28 percent lower than those getting the placebo, the researchers report. The single-drug treatment did reduce blood pressure but did not reduce the risk of stroke.

"The results should have implications for the care of a large number of patients who survive stroke or a transient ischemic attack," the researchers write. "The responsible physician should consider starting treatment at the time of discharge from hospital or at a post-discharge follow-up visit... Although treatment may commence with a single agent, as it did in the run-in phase of this study, the objective should be to move patients onto combination therapy as soon as possible."

That finding is basically sound, says Dr. Jan A. Staessen, professor of medicine at the University of Leuven in Belgium and author of an accompanying editorial, "in the sense that, to some extent, normotensive patients have to be treated."

Page:  1 | 2 | Next >>

Copyright © 2001 ScoutNews, LLC. All rights reserved.
Last updated 9/27/2001

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Interviews with Jan A. Staessen, M.D., Ph.D, professor of medicine, University of Leuven, Belgium; Edgar J. Kenton, M.D., professor of clinical neurology, Thomas Jefferson University, Philadelphia, and chairman of the advisory committee of the American Stroke Association; Sept. 29, 2001, The Lancet


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy